|
1
|
Marley AR and Nan H: Epidemiology of
colorectal cancer. Int J Mol Epidemiol Genet. 7:105–114. 2016.
|
|
2
|
Labianca R, Beretta GD, Kildani B, Milesi
L, Merlin F, Mosconi S, Pessi MA, Prochilo T, Quadri A, Gatta G, et
al: Colon cancer. Crit Rev Oncol Hematol. 74:106–133. 2010.
View Article : Google Scholar
|
|
3
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chiang CJ, Lo WC, Yang YW, You SL, Chen CJ
and Lai MS: Incidence and survival of adult cancer patients in
Taiwan, 2002–2012. J Formos Med Assoc. 115:1076–1088. 2016.
View Article : Google Scholar
|
|
5
|
Siegel RL, Miller KD, Fedewa SA, Ahnen DJ,
Meester RGS, Barzi A and Jemal A: Colorectal cancer statistics,
2017. CA Cancer J Clin. 67:177–193. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lemmens V, van Steenbergen L,
Janssen-Heijnen M, Martijn H, Rutten H and Coebergh JW: Trends in
colorectal cancer in the south of the Netherlands 1975–2007: Rectal
cancer survival levels with colon cancer survival. Acta Oncol.
49:784–796. 2010. View Article : Google Scholar
|
|
7
|
Wu C: Systemic therapy for colon cancer.
Surg Oncol Clin N Am. 27:235–242. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang Z, Zheng L, Yu Y, Wu J, Yang F, Xu
Y, Guo Q, Wu X, Cao S, Cao L and Song X: Involvement of SAMHD1 in
dNTP homeostasis and the maintenance of genomic integrity and
oncotherapy (review). Int J Oncol. 56:879–888. 2020.
|
|
9
|
Tang C, Ji X, Wu L and Xiong Y: Impaired
dNTPase activity of SAMHD1 by phosphomimetic mutation of Thr-592. J
Biol Chem. 290:26352–26359. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Goldstone DC, Ennis-Adeniran V, Hedden JJ,
Groom HC, Rice GI, Christodoulou E, Walker PA, Kelly G, Haire LF,
Yap MW, et al: HIV-1 restriction factor SAMHD1 is a deoxynucleoside
triphosphate triphosphohydrolase. Nature. 480:379–382. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sommer AF, Rivière L, Qu B, Schott K,
Riess M, Ni Y, Shepard C, Schnellbächer E, Finkernagel M,
Himmelsbach K, et al: Restrictive influence of SAMHD1 on hepatitis
B virus life cycle. Sci Rep. 6:266162016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ryoo J, Choi J, Oh C, Kim S, Seo M, Kim
SY, Seo D, Kim J, White TE, Brandariz-Nuñez A, et al: The
ribonuclease activity of SAMHD1 is required for HIV-1 restriction.
Nat Med. 20:936–941. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Antonucci JM, St Gelais C, de Silva S,
Yount JS, Tang C, Ji X, Shepard C, Xiong Y, Kim B and Wu L:
SAMHD1-mediated HIV-1 restriction in cells does not involve
ribonuclease activity. Nat Med. 22:1072–1074. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Leshinsky-Silver E, Malinger G, Ben-Sira
L, Kidron D, Cohen S, Inbar S, Bezaleli T, Levine A, Vinkler C, Lev
D and Lerman-Sagie T: A large homozygous deletion in the SAMHD1
gene causes atypical Aicardi-Goutiéres syndrome associated with
mtDNA deletions. Eur J Hum Genet. 19:287–292. 2011. View Article : Google Scholar
|
|
15
|
Rice GI, Bond J, Asipu A, Brunette RL,
Manfield IW, Carr IM, Fuller JC, Jackson RM, Lamb T, Briggs TA, et
al: Mutations involved in Aicardi-Goutières syndrome implicate
SAMHD1 as regulator of the innate immune response. Nat Genet.
41:829–832. 2009. View
Article : Google Scholar
|
|
16
|
Thiele H, du Moulin M, Barczyk K, George
C, Schwindt W, Nürnberg G, Frosch M, Kurlemann G, Roth J, Nürnberg
P and Rutsch F: Cerebral arterial stenoses and stroke: Novel
features of Aicardi-Goutières syndrome caused by the Arg164X
mutation in SAMHD1 are associated with altered cytokine expression.
Hum Mutat. 31:E1836–E1850. 2010. View Article : Google Scholar
|
|
17
|
Dale RC, Gornall H, Singh-Grewal D,
Alcausin M, Rice GI and Crow YJ: Familial Aicardi-Goutières
syndrome due to SAMHD1 mutations is associated with chronic
arthropathy and contractures. Am J Med Genet A. 152A:938–942. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
de Silva S, Hoy H, Hake TS, Wong HK, Porcu
P and Wu L: Promoter methylation regulates SAMHD1 gene expression
in human CD4+ T cells. J Biol Chem. 288:9284–9292. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
de Silva S, Wang F, Hake TS, Porcu P, Wong
HK and Wu L: Downregulation of SAMHD1 expression correlates with
promoter DNA methylation in Sézary syndrome patients. J Invest
Dermatol. 134:562–565. 2014. View Article : Google Scholar
|
|
20
|
Wang JL, Lu FZ, Shen XY, Wu Y and Zhao LT:
SAMHD1 is down regulated in lung cancer by methylation and inhibits
tumor cell proliferation. Biochem Biophys Res Commun. 455:229–233.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lee EJ, Seo JH, Park JH, Vo TTL, An S, Bae
SJ, Le H, Lee HS, Wee HJ, Lee D, et al: SAMHD1 acetylation enhances
its deoxynucleotide triphosphohydrolase activity and promotes
cancer cell proliferation. Oncotarget. 8:68517–68529. 2017.
View Article : Google Scholar
|
|
22
|
Cribier A, Descours B, Valadao AL,
Laguette N and Benkirane M: Phosphorylation of SAMHD1 by cyclin
A2/CDK1 regulates its restriction activity toward HIV-1. Cell Rep.
3:1036–1043. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rentoft M, Lindell K, Tran P, Chabes AL,
Buckland RJ, Watt DL, Marjavaara L, Nilsson AK, Melin B, Trygg J,
et al: Heterozygous colon cancer-associated mutations of SAMHD1
have functional significance. Proc Natl Acad Sci USA.
113:4723–4728. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Forbes SA, Beare D, Boutselakis H, Bamford
S, Bindal N, Tate J, Cole CG, Ward S, Dawson E, Ponting L, et al:
COSMIC: Somatic cancer genetics at high-resolution. Nucleic Acids
Res. 45(D1): D777–D783. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Doncheva NT, Morris JH, Gorodkin J and
Jensen LJ: Cytoscape StringApp: Network analysis and visualization
of proteomics data. J Proteome Res. 18:623–632. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Felip E, Gutiérrez-Chamorro L, Gómez M,
Garcia-Vidal E, Romeo M, Morán T, Layos L, Pérez-Roca L,
Riveira-Muñoz E, Clotet B, et al: Modulation of DNA damage response
by SAM and HD domain containing deoxynucleoside triphosphate
triphosphohydrolase (SAMHD1) determines prognosis and treatment
efficacy in different solid tumor types. Cancers (Basel).
14:6412022. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Janardhan KS, Jensen H, Clayton NP and
Herbert RA: Immunohistochemistry in investigative and toxicologic
pathology. Toxicol Pathol. 46:488–510. 2018. View Article : Google Scholar
|
|
28
|
Xu C, Zhang W, Liu S, Wu W, Qin M and
Huang J: Activation of the SphK1/ERK/p-ERK pathway promotes
autophagy in colon cancer cells. Oncol Lett. 15:9719–9724.
2018.
|
|
29
|
Yu X, Du Z, Sun X, Shi C, Zhang H and Hu
T: Aberrant Cosmc genes result in Tn antigen expression in human
colorectal carcinoma cell line HT-29. Int J Clin Exp Pathol.
8:2590–2602. 2015.
|
|
30
|
Kim SJ, Kim HJ, Kim HR, Lee SH, Cho SD,
Choi CS, Nam JS and Jung JY: Antitumor actions of baicalein and
wogonin in HT-29 human colorectal cancer cells. Mol Med Rep.
6:1443–1449. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li Q, Zhou X, Fang Z and Zhou H: Knockdown
of KLK12 inhibits viability and induces apoptosis in human
colorectal cancer HT-29 cell line. Int J Mol Med. 44:1667–1676.
2019.PubMed/NCBI
|
|
32
|
Guo H, Wu L, Zhao P and Feng A:
Overexpression of long non-coding RNA zinc finger antisense 1 in
acute myeloid leukemia cell lines influences cell growth and
apoptosis. Exp Ther Med. 14:647–651. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Siddiqui AD and Piperdi B: KRAS mutation
in colon cancer: A marker of resistance to EGFR-I therapy. Ann Surg
Oncol. 17:1168–1176. 2010. View Article : Google Scholar
|
|
34
|
Li N, Zhang W and Cao X: Identification of
human homologue of mouse IFN-gamma induced protein from human
dendritic cells. Immunol Lett. 74:221–224. 2000. View Article : Google Scholar
|
|
35
|
Kueck T, Cassella E, Holler J, Kim B and
Bieniasz PD: The aryl hydrocarbon receptor and interferon gamma
generate antiviral states via transcriptional repression. Elife.
7:e388672018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kodigepalli KM, Li M, Liu SL and Wu L:
Exogenous expression of SAMHD1 inhibits proliferation and induces
apoptosis in cutaneous T-cell lymphoma-derived HuT78 cells. Cell
Cycle. 16:179–188. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Schneider C, Oellerich T, Baldauf HM,
Schwarz SM, Thomas D, Flick R, Bohnenberger H, Kaderali L, Stegmann
L, Cremer A, et al: SAMHD1 is a biomarker for cytarabine response
and a therapeutic target in acute myeloid leukemia. Nat Med.
23:250–255. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Clifford R, Louis T, Robbe P, Ackroyd S,
Burns A, Timbs AT, Wright Colopy G, Dreau H, Sigaux F, Judde JG, et
al: SAMHD1 is mutated recurrently in chronic lymphocytic leukemia
and is involved in response to DNA damage. Blood. 123:1021–1031.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Rossi D: SAMHD1: A new gene for CLL.
Blood. 123:951–952. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Herold N, Rudd SG, Sanjiv K, Kutzner J,
Bladh J, Paulin CBJ, Helleday T, Henter JI and Schaller T: SAMHD1
protects cancer cells from various nucleoside-based
antimetabolites. Cell Cycle. 16:1029–1038. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Rudd SG, Schaller T and Herold N: SAMHD1
is a barrier to antimetabolite-based cancer therapies. Mol Cell
Oncol. 4:e12875542017. View Article : Google Scholar
|
|
42
|
Zhu KW, Chen P, Zhang DY, Yan H, Liu H,
Cen LN, Liu YL, Cao S, Zhou G, Zeng H, et al: Association of
genetic polymorphisms in genes involved in Ara-C and dNTP
metabolism pathway with chemosensitivity and prognosis of adult
acute myeloid leukemia (AML). J Transl Med. 16:902018. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kohnken R, Kodigepalli KM and Wu L:
Regulation of deoxynucleotide metabolism in cancer: Novel
mechanisms and therapeutic implications. Mol Cancer. 14:1762015.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Mauney CH and Hollis T: SAMHD1: Recurring
roles in cell cycle, viral restriction, cancer, and innate
immunity. Autoimmunity. 51:96–110. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wang Z, Bhattacharya A, Villacorta J,
Diaz-Griffero F and Ivanov DN: Allosteric activation of SAMHD1
protein by deoxynucleotide triphosphate (dNTP)-dependent
tetramerization requires dNTP concentrations that are similar to
dNTP concentrations observed in cycling T cells. J Biol Chem.
291:21407–21413. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Bonifati S, Daly MB, St Gelais C, Kim SH,
Hollenbaugh JA, Shepard C, Kennedy EM, Kim DH, Schinazi RF, Kim B
and Wu L: SAMHD1 controls cell cycle status, apoptosis and HIV-1
infection in monocytic THP-1 cells. Virology. 495:92–100. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Herrmann A, Wittmann S, Thomas D, Shepard
CN, Kim B, Ferreirós N and Gramberg T: The SAMHD1-mediated block of
LINE-1 retroelements is regulated by phosphorylation. Mob DNA.
9:112018. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Yang CA, Huang HY, Chang YS, Lin CL, Lai
IL and Chang JG: DNA-sensing and nuclease gene expressions as
markers for colorectal cancer progression. Oncology. 92:115–124.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Jiang H, Li C and Liu Z: Shengjing
Hospital and Hu: Expression and relationship of SAMHD1 with other
apoptotic and autophagic genes in acute myeloid leukemia patients.
Acta Haematol. 143:51–59. 2020. View Article : Google Scholar
|
